Literature DB >> 33668420

Autoimmunity and Genetic Syndromes: A Focus on Down Syndrome.

Marta Ferrari1, Stefano Stagi1.   

Abstract

Within immune system-related diseases, autoimmunity has always represented a field of great interest, although many aspects remain poorly understood even today. Genetic syndromes associated with immunity disorders are common and represent an interesting model for a better understanding of the underlying mechanism of autoimmunity predisposition. Among these conditions, Down syndrome (DS) certainly deserves special attention as it represents the most common genetic syndrome associated with immune dysregulation, involving both innate and adaptive immunity. Autoimmunity represents a well-known complication of DS: it is estimated that people affected by this disease present a risk four to six times higher than the normal population to develop autoimmune diseases such as celiac disease, type 1 diabetes mellitus, and hypo- or hyperthyroidism. Several factors have been considered as possible etiology, including genetic and epigenetic modifications and immune dysregulation. In times in which the life expectancy of people with DS has been extremely prolonged, thanks to improvements in the diagnosis and treatment of congenital heart disease and infectious complications, knowledge of the mechanisms and proper management of autoimmune diseases within this syndrome has become essential. In this short review, we aim to report the current literature regarding the genetic, immune, and environmental factors that have been proposed as the possible underlying mechanism of autoimmunity in individuals with DS, with the intent to provide insight for a comprehensive understanding of these diseases in genetic syndromes.

Entities:  

Keywords:  Down syndrome; autoimmunity; immune dysregulation

Mesh:

Year:  2021        PMID: 33668420      PMCID: PMC7918365          DOI: 10.3390/genes12020268

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  39 in total

1.  Thyroid dysfunction in patients with Down syndrome: Results from a multi-institutional registry study.

Authors:  Jenifer Lavigne; Christianne Sharr; Ibrahim Elsharkawi; Al Ozonoff; Nicole Baumer; Campbell Brasington; Sheila Cannon; Blythe Crissman; Emily Davidson; Jose C Florez; Priya Kishnani; Angela Lombardo; Jordan Lyerly; Mary Ellen McDonough; Alison Schwartz; Kathryn Berrier; Susan Sparks; Kara Stock-Guild; Tomi L Toler; Kishore Vellody; Lauren Voelz; Brian G Skotko
Journal:  Am J Med Genet A       Date:  2017-03-23       Impact factor: 2.802

2.  Chromosome 21-Encoded microRNAs (mRNAs): Impact on Down's Syndrome and Trisomy-21 Linked Disease.

Authors:  P N Alexandrov; M E Percy; Walter J Lukiw
Journal:  Cell Mol Neurobiol       Date:  2017-07-07       Impact factor: 5.046

3.  Autoimmune disease and multiple autoantibodies in 42 patients with RASopathies.

Authors:  Caio R D C Quaio; Jozélio F Carvalho; Clovis A da Silva; Cleonice Bueno; Amanda S Brasil; Alexandre C Pereira; Alexander A L Jorge; Alexsandra C Malaquias; Chong A Kim; Débora R Bertola
Journal:  Am J Med Genet A       Date:  2012-04-09       Impact factor: 2.802

Review 4.  Drugs and autoimmunity--a contemporary review and mechanistic approach.

Authors:  Christopher Chang; M Eric Gershwin
Journal:  J Autoimmun       Date:  2009-12-16       Impact factor: 7.094

5.  Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation.

Authors:  Kelly D Sullivan; Donald Evans; Ahwan Pandey; Thomas H Hraha; Keith P Smith; Neil Markham; Angela L Rachubinski; Kristine Wolter-Warmerdam; Francis Hickey; Joaquin M Espinosa; Thomas Blumenthal
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

6.  Immune Defect in Adults With Down Syndrome: Insights Into a Complex Issue.

Authors:  Yannick Dieudonné; Beatrice Uring-Lambert; Mohamed Maxime Jeljeli; Vincent Gies; Yves Alembik; Anne-Sophie Korganow; Aurélien Guffroy
Journal:  Front Immunol       Date:  2020-05-08       Impact factor: 7.561

7.  Autoimmune Mechanisms of Interferon Hypersensitivity and Neurodegenerative Diseases: Down Syndrome.

Authors:  Ashraya Jagadeesh; Leonard E Maroun; Lisa M Van Es; Richard M Millis
Journal:  Autoimmune Dis       Date:  2020-06-01

8.  Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development.

Authors:  Genni Enza Marcovecchio; Ileana Bortolomai; Francesca Ferrua; Elena Fontana; Luisa Imberti; Erika Conforti; Donato Amodio; Sonia Bergante; Giulia Macchiarulo; Veronica D'Oria; Francesca Conti; Silvia Di Cesare; Georgia Fousteri; Adriano Carotti; Alessandro Giamberti; Pietro Luigi Poliani; Luigi D Notarangelo; Caterina Cancrini; Anna Villa; Marita Bosticardo
Journal:  Front Immunol       Date:  2019-03-15       Impact factor: 7.561

Review 9.  The interferons and their receptors--distribution and regulation.

Authors:  Nicole A de Weerd; Thao Nguyen
Journal:  Immunol Cell Biol       Date:  2012-03-13       Impact factor: 5.126

Review 10.  Down Syndrome and COVID-19: A Perfect Storm?

Authors:  Joaquin M Espinosa
Journal:  Cell Rep Med       Date:  2020-05-01
View more
  3 in total

1.  COVID-19 and Down syndrome: the spark in the fuel.

Authors:  Manini Majithia; Susan P Ribeiro
Journal:  Nat Rev Immunol       Date:  2022-07       Impact factor: 108.555

2.  Altered spontaneous brain activity in Down syndrome and its relation with cognitive outcome.

Authors:  Cristina Cañete-Massé; Maria Carbó-Carreté; Maribel Peró-Cebollero; Shi-Xian Cui; Chao-Gan Yan; Joan Guàrdia-Olmos
Journal:  Sci Rep       Date:  2022-09-14       Impact factor: 4.996

3.  Special Issue: Autoimmune Disease Genetics.

Authors:  Malgorzata Gabriela Wasniewska; Artur Bossowski
Journal:  Genes (Basel)       Date:  2021-11-30       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.